CD4 and neoplasm: In addition, it has also been proposed that the milieu of the tumour microenvironment converts effector CD4+ T cells into Tregs or promotes the differentiation of naïve CD4+ T cells into induced Tregs [62, 63], further exacerbating suppression of nascent anti-tumour immunity.